Fig. 2.
Plasma concentration versus time profiles of pasireotide in patients with gastroenteropancreatic neuroendocrine tumor (GEP NET) after three monthly injections. LAR Long-acting release
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.